All Comments by

  1. Alexei Koudinov on Apolipoprotein E: a major piece in the Alzheimer's disease puzzle.
  2. Alexei Koudinov on Barriers to Alzheimer disease drug discovery and drug development in the pharmaceutical industry.
  3. Alexei Koudinov on Barriers to drug discovery and development for Alzheimer disease.
  4. Alexei Koudinov on Barriers to Alzheimer disease drug discovery and development in academia.
  5. Alexei Koudinov on MAP-2 immunolabeling can distinguish diffuse from dense-core amyloid plaques in brains with Alzheimer's disease.
  6. Alexei Koudinov on Beta-amyloid catabolism: roles for neprilysin (NEP) and other metallopeptidases?
  7. Alexei Koudinov on Parkinson's disease: one biochemical pathway to fit all genes?
  8. Alexei Koudinov on The treatment of Alzheimer's disease: where have we been, and where are we going?
  9. Alexei Koudinov on Potential novel targets for Alzheimer pharmacotherapy: I. Secretases.
  10. Alexei Koudinov on Apolipoproteins and aging: emerging mechanisms.
  11. Alexei Koudinov on Parkinson's disease mimicking senile dementia of the Alzheimer type: a clinicopathological study of four autopsy cases.
  12. Alexei Koudinov on Toxicity of substrate-bound amyloid peptides on vascular smooth muscle cells is enhanced by homocysteine.
  13. Alexei Koudinov on By the way, doctor. I read in the paper that cholesterol might be good for the brain and prevent Alzheimer's disease. So I'm wondering if taking a statin is really such a good idea.
  14. Alexei Koudinov on Passive immunization against beta-amyloid peptide protects central nervous system (CNS) neurons from increased vulnerability associated with an Alzheimer's disease-causing mutation.
  15. Alexei Koudinov on A novel function of monomeric amyloid beta-protein serving as an antioxidant molecule against metal-induced oxidative damage.